🇿🇦 We look forward to seeing you in America 🇺🇸
We provide the unique opportunity for South African investors to participate in the rapidly growing US Med Spa and Wellness industry with an initial investment of just $50,000, as well as possible Greencard routes available.
In 2024, the GLP-1 weight loss market in the USA is booming, with drugs like semaglutide and tirzepatide (the active ingredients in the FDA-approved weight loss drugs Ozempic™ and Mounjaro™) driving rapid growth and a projected CAGR of 20-25% over the next five years. This expansion is fueled by rising obesity rates, greater treatment adoption, and broader insurance coverage. For investors, this represents a prime opportunity in a sector poised for innovation and success. Additionally, the U.S. medical spa market, valued at $7.36 billion in 2023, is set to grow at a 14.0% CAGR from 2024 to 2032, highlighting strong demand for integrative wellness services and significant potential for market capture. We are strategically positioned for growth in the booming wellness industry. This investment opportunity is an up and coming business in the integrative wellness sector, dedicated to delivering high-quality medical spa services that significantly enhance the health and well-being of our clients. With a robust focus on customer-centric operations, we aim to set new standards in luxury wellness through our innovative treatments, collaborative initiatives, and unwavering commitment to exceptional customer service. Our multi-national South African and American team is guided by a leadership with extensive experience in corporate business transformation, integrative medicine, and the medical spa wellness industry.
Our service includes a comprehensive consult to help identify gaps and opportunities, and results in a comprehensive report that includes a project plan with timelines a cost analysis. Our individualized plans are made up of quality services that will help you get there quickly and smoothly. For South African investors looking to explore opportunities in the US, our investment structure offers a seamless and compliant pathway to capitalize on the robust American economy. Investors can choose between three main options: utilizing their annual Forex allowance for direct investment, participating through our Special Purpose Vehicle (SPV), or making a direct offshore investment with existing foreign currency holdings. We also handle all compliance and reporting, ensuring a hassle-free experience while offering attractive returns in high-growth sectors such as health, beauty, and wellness. In addition to financial returns, further potential investment options may also serve as a strategic step toward possibly obtaining a US green card. By choosing optional route, investors not only gain the potential for higher levels of participation in U.S. businesses but also open the door to future immigration plans, offering a path for investors and their families to establish a life in the U.S. Whether your goal is wealth growth, diversification, or a new beginning abroad, our investment structure provides the flexibility and security needed to achieve your end goals.
We operate on a lean and scalable business model that requires minimal upfront capital expenditure. Our practice offers high-quality, revenue generating services through standardized clinical protocols and centralized operations, including marketing, staffing, compliance management, and procurement. This centralized model ensures operational efficiency, reduces logistical burdens, and maintains consistent service levels across all locations. Our business model is designed for rapid expansion with a minimal initial investment and a short burn rate of less than six months. Emphasizing a "just add water" approach, we maintain a lean and clean operational framework that minimizes capital expenditure and infrastructure requirements. Established and clinically validated standard operating procedures (SOPs), along with bespoke practitioner training, ensure service level homogeneity and consistent outcomes across practices. We pride ourselves on core value propositions that set us apart in the competitive wellness services landscape. Central to our operations is our unwavering commitment to exceptional customer service. Our membership model focuses on rewards and long-term engagement, offering members significant benefits such as discounts, complimentary treatments, and priority access to services. These programs are crafted to minimize patient attrition by keeping clients actively involved in continuous, largely prepaid plans. This approach not only boosts client loyalty but also ensures they complete their wellness journeys, leading to optimal outcomes.
Expansion plans are set for Florida, targeting affluent areas with high demand for luxury wellness services, and extends to other high-potential regions hand selected across the State. This precision approach minimizes risk and maximizes market penetration, offering a strong foundation for investor success. The strategy starts in South Florida, targeting high-end boutique wellness spas in Palm Beach, Broward, and Miami-Dade counties. It will then extend to Central and West Florida, including Naples, Tampa, St. Petersburg, and Orlando. Each new location is expected to
generate $0.7 to $1.1 million annually within 24 months.*
The information provided on this website is for informational purposes only and does not constitute financial, legal, or immigration advice. While we aim to provide accurate and timely information regarding investment opportunities and potential U.S. green card options, there are no guarantees regarding the success or performance of any investment or the issuance of a green card. Investments involve risks, including the potential loss of principal. You should carefully consider these risks and consult with your financial advisor and legal counsel before making any investment decisions. We make no warranties or representations about the accuracy, completeness, or reliability of the information contained on this website. By using this website, you agree to release and hold harmless MyBizUSA, its affiliates, and their respective officers, directors, employees, and agents from any claims, losses, liabilities, or damages arising from or related to your use of this website or reliance on any information provided herein. Investment results and green card approvals can vary based on individual circumstances and external factors beyond our control. Any statements regarding potential outcomes are speculative and should not be considered as guarantees. For personalized advice and to address specific concerns, please seek the counsel of a qualified professional. The FDA-approved brand name drugs, such as Wegovy®, and Ozempic® are exclusively available from the Novo Nordisk™ company. Mounjaro™ is exclusively available from Eli Lilly and Company™. MyBizUSA does not claim any affiliation with, or endorsement from, the above mentioned products or entities. We do not offer any of the above mentioned products, anyone seeking said products should discuss options with their licensed healthcare provider or pharmacist.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.